Delivery Order SPE2DB22D1103-SPE2DB25FTNV8
- Not listed
- The Defense Logistics Agency awarded a $23,290.99 delivery order to AmerisourceBergen Drug Corp for Prolia 60 mg/ml syringes, with an ultimate completion date of September 8, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99...
- The Defense Logistics Agency awarded a delivery order valued at $33,324.63 to AmerisourceBergen Drug Corp for Prolia 60 mg/ml syringes, with an ultimate completion date of September 18, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,723.10 by the Defense Logistics Agency on August 5, 2025, for the supply of Prolia 60 mg/ml syringes. The contract utilizes firm fixed price terms and carries an ultimate completion date of August 6, 2025. This award is unset-aside and was competitively awarded through the federal procurement process. The delivery order will be fulfilled from the vendor's Corporate Office...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order for PROLIA 60 mg/mL syringes valued at $13,150.17 by the Defense Logistics Agency on September 16, 2025. This firm fixed-price delivery order, with an ultimate completion date of September 17, 2025, represents a non-competitive award issued under an existing contract vehicle. The award will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, and fulfills...
- The Defense Logistics Agency awarded a $18,350.75 delivery order to AmerisourceBergen Drug Corp for Prolia 60 mg/ml syringes, with an ultimate completion date of August 27, 2025. This non-set-aside, firm fixed price contract was competitively awarded on August 26, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for...
- The Defense Logistics Agency awarded a delivery order valued at $15,697.68 to AmerisourceBergen Drug Corp for Prolia 60 mg/ml syringes, with an ultimate completion date of September 4, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken. This delivery order is issued under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on July 18, 2025, valued at $14,789.72 for the supply of Prolia 60 mg/mL syringes. This firm fixed-price delivery order, which is set to be completed by July 21, 2025, was competitively awarded without set-aside provisions and is funded through the Medical Supply Chain, a defense-oriented federal agency. The award represents a child contract under...
- The Defense Logistics Agency (DLA) awarded a Delivery Order valued at $14,887.74 to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Prolia 60 mg/ml syringes. This non-set-aside, firm fixed price contract is scheduled for completion by August 20, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $14,539.96 to AmerisourceBergen Drug Corp for Prolia 60 mg/ml syringes, with an ultimate completion date of September 8, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor's Corporate Office located in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger indefinite delivery contract vehicle with...
- The Defense Logistics Agency awarded a delivery order valued at $16,071.75 to AmerisourceBergen Drug Corp for Prolia 60 mg/ml syringes, with an ultimate completion date of August 5, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB25FTNV8Delivery Order
The Defense Logistics Agency awarded a $2,142.90 delivery order to AmerisourceBergen Drug Corp for Prolia 60 mg/ml syringes, with an ultimate completion date of June 4, 2025. This contract employs firm fixed price pricing and represents a non-set-aside, competitively awarded procurement. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (contract number SPE2DX), a $999.999 billion pharmaceutical prime vendor agreement running through December 2026 that serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor headquartered in Conshohocken, Pennsylvania. The company maintains an extensive portfolio of federal contract awards predominantly with the Defense Logistics Agency and Medical Supply Chain, supplying a wide range of pharmaceutical products and medical supplies including brand-name and generic medications, vaccines, medical devices, and specialty healthcare commodities. The company's demonstrated capability to meet federal procurement requirements through open competition, combined with its substantial prime vendor agreement with DLA, positions it as a key supplier supporting military healthcare systems and other federal customers worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 6/3/25 |